Kawasaki disease can be fatal, but with timely treatment, death is extremely rare. In the United States, the in-hospital mortality rate is approximately 0.17%, and in Japan, where the disease is most common, the case fatality rate is even lower at 0.015%. Nearly all deaths from Kawasaki disease are caused by damage to the coronary arteries, the blood vessels that supply the heart. The key factor separating a good outcome from a dangerous one is how quickly treatment begins.
How Kawasaki Disease Can Be Fatal
Kawasaki disease is a condition that causes inflammation in blood vessel walls, and it has a particular tendency to target the coronary arteries. Without treatment, roughly 25% of children develop coronary artery aneurysms, which are balloon-like weak spots in these critical blood vessels. These aneurysms can lead to blood clots forming inside the artery, blocking blood flow to the heart muscle. When that happens, the result is a heart attack, even in a young child.
In the most severe cases, an aneurysm can rupture. Sudden cardiac death, though very rare, has been documented in children with undiagnosed or undertreated Kawasaki disease. A review of pediatric vasculitis deaths over 50 years in Japan found that the vast majority were caused by Kawasaki disease, though fatality rates dropped dramatically once effective treatment became standard in the mid to late 1980s.
The Treatment Window That Matters Most
The standard treatment is a high-dose infusion of immunoglobulin (a blood product that calms the immune system) given alongside aspirin. Current guidelines from the American Heart Association recommend starting this treatment within the first 10 days of illness, and ideally within the first 7 days. Children treated within that 7-day window have a significantly lower risk of developing coronary artery damage. Those treated after 10 days face a notably higher rate of complications during follow-up.
This is why early diagnosis is so important. Kawasaki disease is identified by a combination of symptoms: persistent high fever lasting at least four days, a rash, red eyes without discharge, swollen or red hands and feet, swollen lymph nodes on one side of the neck, and changes in the mouth like a bright red “strawberry tongue” or cracked lips. When four or more of these features appear alongside the fever, experienced doctors can make the diagnosis quickly and begin treatment.
When Initial Treatment Doesn’t Work
About 10% to 20% of children don’t respond to the first round of treatment, meaning their fever persists. These cases are considered refractory, and they carry a higher risk of heart complications. Doctors typically move to a second-line approach: a repeat dose of the same immunoglobulin infusion, a course of steroids, or an anti-inflammatory biologic medication. Research comparing these options found that the biologic medication resolved fever in about 88% of refractory cases, compared to roughly 72% to 73% for the other two options.
Infants Face the Highest Risk
Babies under six months old are particularly vulnerable. They account for 3% to 17% of Kawasaki disease cases depending on the study, and they’re more likely to present with an incomplete form of the disease, meaning fewer of the classic symptoms show up. That makes diagnosis harder and delays treatment. Even when diagnosed and treated on time, more than 25% of infants under six months with an initially normal heart scan went on to develop coronary artery changes in one study.
The size of the child also matters when interpreting test results. A 5-millimeter aneurysm in a 3-month-old represents far greater severity and a much higher clotting risk than the same measurement in a teenager, simply because of the difference in body and artery size. Boys, children under 12 months, and those with certain lab abnormalities (low sodium, low albumin, elevated liver enzymes) are all considered higher risk for coronary complications.
Long-Term Heart Risks for Survivors
For the majority of children who recover without any coronary artery damage, the long-term outlook is excellent. Studies have found that these patients actually have a lower mortality rate than the general population over time. But children who develop severe coronary aneurysms carry that risk into adulthood.
As the earliest generations of Kawasaki disease survivors now reach their 30s and 40s, doctors are seeing a pattern of late cardiovascular complications: heart attacks, chronic coronary artery disease, heart failure, and abnormal heart rhythms. These events tend to cluster in young adults, particularly men, with a second surge appearing in the late 30s. Notably, these complications occur even in patients without traditional risk factors like obesity, which means the childhood artery damage itself is the driver.
Children who had significant coronary involvement typically need long-term follow-up with a cardiologist, sometimes including ongoing use of low-dose aspirin or other blood-thinning medications for years or even indefinitely.
Recurrence Is Uncommon but Possible
A small number of children get Kawasaki disease more than once. Recurrence rates range from about 0.8% in the United States to 3% in Japan. In very rare cases (around 0.2%), children experience multiple recurrences. Each episode carries its own risk of coronary damage, so recurrent cases are treated with the same urgency as the first.